Phase III study of surgery versus definitive concurrent chemoradiotherapy boost in patients with resectable stage IIIA(N2) and selected IIIB non-small-cell lung cancer after induction chemotherapy and concurrent chemoradiotherapy (ESPATUE) - Eberhardt, W EE; Pöttgen, C; Gauler, T C (J Clin Oncol, 2015)
, et al.